Provided by Tiger Trade Technology Pte. Ltd.

BioAge Labs Inc.

20.51
-0.2200-1.06%
Post-market: 20.510.00000.00%16:49 EST
Volume:452.08K
Turnover:9.22M
Market Cap:856.34M
PE:-9.71
High:21.43
Open:21.42
Low:19.42
Close:20.73
52wk High:24.00
52wk Low:2.88
Shares:41.75M
Float Shares:28.58M
Volume Ratio:0.66
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1117
EPS(LYR):-6.6293
ROE:-25.64%
ROA:-17.46%
PB:3.09
PE(LYR):-3.09

Loading ...

Morgan Stanley Boosts Price Target on BioAge Labs to $23 From $12, Keeps Equalweight Rating

MT Newswires Live
·
Feb 04

BioAge Labs Initiated at Overweight by Piper Sandler

Dow Jones
·
Jan 27

BioAge Labs initiated with an Overweight at Piper Sandler

TIPRANKS
·
Jan 27

BioAge Labs: De-Risked NLRP3 Program and 2026 Clinical Catalysts Underpin Overweight/Buy Rating

TIPRANKS
·
Jan 27

U.S. RESEARCH ROUNDUP-AMETEK, Stryker, Zimmer Biomet Holdings

Reuters
·
Jan 27

Bioage Labs Inc : Piper Sandler Initiates Coverage With Overweight Rating; Price Target $73

THOMSON REUTERS
·
Jan 27

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel

Reuters
·
Jan 23

BUZZ-U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital

Reuters
·
Jan 22

BUZZ-BioAge Labs edges down after stock sale hiked to $115 mln

Reuters
·
Jan 22

BRIEF-Bioage Announces Pricing Of Upsized $115 Million Public Offering

Reuters
·
Jan 22

Bioage Announces Pricing of Upsized $115.0 Million Public Offering

THOMSON REUTERS
·
Jan 22

BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies

Reuters
·
Jan 21

BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous

Reuters
·
Jan 21

BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating

TIPRANKS
·
Jan 21

BioAge Labs Proposes Public Offering Worth $75 Million

MT Newswires Live
·
Jan 21

BioAge Labs announces $75M common stock offering

TIPRANKS
·
Jan 21

Bioage Labs Inc - to Offer up to $75 Mln of Common Stock

THOMSON REUTERS
·
Jan 21

Bioage Announces Proposed Public Offering

THOMSON REUTERS
·
Jan 21

BioAge Labs management to meet with Piper Sandler

TIPRANKS
·
Jan 21

BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines

TIPRANKS
·
Jan 21